Actively Recruiting

Phase Not Applicable
Age: 25Years - 75Years
All Genders
NCT06694636

Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma

Led by Zhongda Hospital · Updated on 2024-11-19

5

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Patients who met the inclusion criteria were treated with endovascular radiofrequency ablation and desympathetic nerve surgery. After enrollment, endovascular radiofrequency ablation and desympathetic surgery were performed. After radiofrequency ablation, the safety and efficacy of follow-up treatment will be carried out every 1 month or so, including blood routine, liver and kidney function, tumor indicators, abdominal CT/magnetic resonance, etc.

CONDITIONS

Official Title

Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma

Who Can Participate

Age: 25Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinically or pathologically confirmed hepatocellular carcinoma (HCC)
  • Locally progressed or distant metastatic unresectable advanced HCC
  • Progressed after second-line therapy
  • Agree to participate in the study and sign the informed consent form
Not Eligible

You will not qualify if you...

  • Not suitable for ablation surgery
  • Pregnant, lactating and planning to become pregnant
  • Orthostatic hypotension
  • Mixed liver cancer
  • Intestinal obstruction
  • Obvious bleeding tendencies and hematologic diseases
  • Acute or severe systemic infection
  • Stroke or transient ischemic attack (TIA) within two weeks
  • Acute coronary syndrome within two weeks
  • Evaluated to be not suitable for this trial by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhongda Hospital

Nanjing, Jiangsu, China, 210009

Actively Recruiting

Loading map...

Research Team

H

Hai-Dong Zhu

CONTACT

T

Teng

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here